Trial intelligence / Profile preview

Salagen vs Submandibular Gland Transfer for Radiation-Induced Xerostomia

NCT00168181Phase 3Completed

Sponsor
Alberta Health Services
Start
Apr 2002
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of pilocarpine in xerostomia, sponsored by Alberta Health Services. Started Apr 2002; status: completed.

02

Drugs

pilocarpine
03

Conditions

xerostomia

Beyond the preview

Go deeper on NCT00168181.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00168181.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call